JP2005518355A5 - - Google Patents

Download PDF

Info

Publication number
JP2005518355A5
JP2005518355A5 JP2003545347A JP2003545347A JP2005518355A5 JP 2005518355 A5 JP2005518355 A5 JP 2005518355A5 JP 2003545347 A JP2003545347 A JP 2003545347A JP 2003545347 A JP2003545347 A JP 2003545347A JP 2005518355 A5 JP2005518355 A5 JP 2005518355A5
Authority
JP
Japan
Prior art keywords
composition according
receptor ligand
toll receptor
composition
proteolytic activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003545347A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005518355A (ja
Filing date
Publication date
Priority claimed from GBGB0127618.7A external-priority patent/GB0127618D0/en
Application filed filed Critical
Publication of JP2005518355A publication Critical patent/JP2005518355A/ja
Publication of JP2005518355A5 publication Critical patent/JP2005518355A5/ja
Pending legal-status Critical Current

Links

JP2003545347A 2001-11-17 2002-11-18 創傷を治療するための組成物及び方法 Pending JP2005518355A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0127618.7A GB0127618D0 (en) 2001-11-17 2001-11-17 "Composition and method for treatment of wounds"
PCT/GB2002/005171 WO2003043669A1 (en) 2001-11-17 2002-11-18 Composition and method for treatment of wounds

Publications (2)

Publication Number Publication Date
JP2005518355A JP2005518355A (ja) 2005-06-23
JP2005518355A5 true JP2005518355A5 (enExample) 2006-01-19

Family

ID=9925971

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003545347A Pending JP2005518355A (ja) 2001-11-17 2002-11-18 創傷を治療するための組成物及び方法

Country Status (8)

Country Link
US (1) US20050053597A1 (enExample)
EP (1) EP1450872A1 (enExample)
JP (1) JP2005518355A (enExample)
CN (1) CN1612756A (enExample)
AU (1) AU2002366000B2 (enExample)
CA (1) CA2467246A1 (enExample)
GB (2) GB0127618D0 (enExample)
WO (1) WO2003043669A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0607495D0 (en) * 2006-04-13 2006-05-24 Secr Defence Larval enzymes
JP4998999B2 (ja) * 2007-09-11 2012-08-15 国立大学法人 岡山大学 ウジムシ治療用のカバードレッシング
EP2226382A1 (en) * 2009-03-03 2010-09-08 B.R.A.I.N. Biotechnology Research and Information Network AG Protease for wound conditioning and skin care
CN101780279B (zh) * 2009-12-22 2012-07-11 中山大学中山眼科中心 Toll-like receptor-3激动剂在制备促进伤口愈合的药物中的应用
CN102675409A (zh) * 2012-04-25 2012-09-19 大连医科大学附属第一医院 可保持五谷虫分泌排泄物活性的收集液
CN111285922B (zh) * 2020-03-03 2022-06-10 南京中医药大学 一种促进组织修复的果蝇多肽及其制备方法与应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2187766A (en) * 1936-12-10 1940-01-23 Standard Chemical And Mineral Therapeutic composition
ES2279572T3 (es) * 1997-05-07 2007-08-16 Schering Corporation Proteinas receptoras humanas de tipo toll, reactivos y metodos relacionados.
DE29924318U1 (de) * 1999-01-14 2002-09-19 Fleischmann, Wilhelm, Dr.med., 74321 Bietigheim-Bissingen Verbandsmaterial
GB9925005D0 (en) * 1999-10-22 1999-12-22 Univ Nottingham The treatment of wounds
US20030134283A1 (en) * 2000-10-03 2003-07-17 Peterson David P. Genes regulated in dendritic cell differentiation
DE10138303A1 (de) * 2001-08-10 2003-03-06 Aventis Pharma Gmbh Verwendung von Enzymisolaten aus Fliegenlarven zur Wundbehandlung

Similar Documents

Publication Publication Date Title
ATE364698T1 (de) Neues, physiologisch aktives peptid und dessen verwendung
EP2679235A3 (en) Peptides and related molecules that modulate nerve growth factor activity
NZ606504A (en) Modified proteases that inhibit complement activation
RU2008136324A (ru) Желудочно-кишечный пролиферативный фактор и его применения
ATE429922T1 (de) Topische gel-abgabesysteme zur behandlung von hauterkrankungen
ATE497390T1 (de) Neue therapeutische verwendung von smr-1 peptide
WO2004056307A3 (en) Disease treatment via antimicrobial peptide inhibitors
PL350627A1 (en) Medicament for treating diabetes
WO2003039454A3 (en) Beta-secretase inhibitors and methods of use
FI954978A0 (fi) Modifioidut proteiini- ja peptidilääkeaineet
DE60135996D1 (de) Peptidzusammensetzungen zur behandlung periodontaler krankheiten und prävention der hautalterung
JP2006131633A5 (enExample)
JP2005518355A5 (enExample)
DE60136909D1 (de) Arzneimittel mit anemonin als aktivum zur behandlung von aseptischer inflammation
DE60228878D1 (de) Proteine mit il-6 inhibitorischer wirkung
DE60044584D1 (de) Protease from lucilia sericata und deren verwendung zur wundheilung
WO2006114105A8 (en) Use of modified factor vii for treating bleeding
DE60227670D1 (de) Aminosäuren-enthaltende zusammensetzungen, geeignet zur wundheilung, insbesondere zur behandlung des auges
WO2004064786A3 (en) Article for debridement and detoxification of wounds
WO2002088180A3 (en) Use of alpha 1-antichymotrypsin for the manufacture of a composition for treatment, prevention or diagnosis of poorly healing diabetic or arterial wounds
DE60128084D1 (de) Verwendung von inaktives cln2 proenzym zur behandlung von lincl
ATE536366T1 (de) Peptidinhibitoren von hk2 und deren anwendung
ATE446766T1 (de) Verwendung von alpha-s2 casein vorläufer- abgeleiteten peptiden
ATE203680T1 (de) Konjugat zur behandlung von entzündungserkrankungen
RU99101827A (ru) Фармацевтическая композиция для лечения вирусных заболеваний